{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:26:49Z","timestamp":1793305609123,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.dld.2026.03.017","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:22:05Z","timestamp":1779103325000},"page":"925-934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Explainable machine learning incorporating CHI3L1 enhances liver fibrosis staging in chronic hepatitis B: The CHILI multicenter study"],"prefix":"10.1016","volume":"58","author":[{"given":"Qingxian","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4909-4667","authenticated-orcid":false,"given":"Wenfang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuxin","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6482-316X","authenticated-orcid":false,"given":"Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6313-5808","authenticated-orcid":false,"given":"Yinjing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7670-7234","authenticated-orcid":false,"given":"Wenwen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2026.03.017_bib0001","series-title":"Global hepatitis report 2024: action for access in low-and middle-income countries","year":"2024"},{"issue":"1","key":"10.1016\/j.dld.2026.03.017_bib0002","doi-asserted-by":"crossref","first-page":"66","DOI":"10.21037\/hbsn-2024-754","article-title":"2024 latest report on hepatitis B virus epidemiology in China: current status, changing trajectory, and challenges","volume":"14","author":"Yan","year":"2025","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.dld.2026.03.017_bib0003","series-title":"Seminars in liver disease","first-page":"001","article-title":"Regression of liver fibrosis","author":"Campana","year":"2017"},{"issue":"8","key":"10.1016\/j.dld.2026.03.017_bib0004","doi-asserted-by":"crossref","first-page":"101436","DOI":"10.1016\/j.jhepr.2025.101436","article-title":"Prioritising viral hepatitis elimination to prevent hepatocellular carcinoma: a public health approach for effective preventive hepatology","volume":"7","author":"Wajcman","year":"2025","journal-title":"JHEP Rep"},{"issue":"5","key":"10.1016\/j.dld.2026.03.017_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23200","article-title":"The clinical significance of serum chitinase 3-like 1 in hepatitis B\u2013related chronic liver diseases","volume":"34","author":"Jiang","year":"2020","journal-title":"J Clin Lab Anal"},{"issue":"6","key":"10.1016\/j.dld.2026.03.017_bib0006","first-page":"1425","article-title":"Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)","volume":"11","author":"You","year":"2023","journal-title":"J Clin Transl Hepatol"},{"issue":"6","key":"10.1016\/j.dld.2026.03.017_bib0007","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jhep.2007.07.022","article-title":"The clinical significance of persistently normal ALT in chronic hepatitis B infection","volume":"47","author":"Lai","year":"2007","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2026.03.017_bib0008","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1053\/j.gastro.2008.02.075","article-title":"Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT","volume":"134","author":"Kumar","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.dld.2026.03.017_bib0009","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cgh.2008.02.037","article-title":"Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels","volume":"6","author":"Tsang","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2026.03.017_bib0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/HEP.0000000000000845","article-title":"AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis","volume":"81","author":"Sterling","year":"2025","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.dld.2026.03.017_bib0011","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s12072-008-9114-x","article-title":"Liver fibrosis: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)","volume":"3","author":"Shiha","year":"2009","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.dld.2026.03.017_bib0012","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.dld.2026.03.017_bib0013","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/HEP.0000000000000842","article-title":"Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: a systematic review supporting the AASLD Practice Guideline","volume":"81","author":"Patel","year":"2025","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.dld.2026.03.017_bib0014","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.dld.2026.03.017_bib0015","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/0016-5085(90)91167-5","article-title":"A 21-year experience with major hemorrhage after percutaneous liver biopsy","volume":"99","author":"McGill","year":"1990","journal-title":"Gastroenterology"},{"issue":"21","key":"10.1016\/j.dld.2026.03.017_bib0016","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.3748\/wjg.14.3396","article-title":"Why, who and how should perform liver biopsy in chronic liver diseases","volume":"14","author":"Sporea","year":"2008","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.dld.2026.03.017_bib0017","article-title":"Aspartate aminotransferase-to-platelet ratio index (APRi) as biomarker for liver damage in biliary atresia (BA): a meta-analysis","author":"Brits","year":"2025","journal-title":"J Pediatr Surg"},{"issue":"7","key":"10.1016\/j.dld.2026.03.017_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2024.108777","article-title":"FIB-4 as a screening and disease monitoring method in pre-fibrotic stages of metabolic dysfunction-associated fatty liver disease (MASLD)","volume":"38","author":"Albert","year":"2024","journal-title":"J Diabetes Complicat"},{"issue":"2","key":"10.1016\/j.dld.2026.03.017_bib0019","article-title":"Diagnostic value of serologic biomarkers for the detection of liver fibrosis in non-alcoholic fatty liver disease","volume":"16","author":"Mohammadi","year":"2025","journal-title":"Casp J Intern Med"},{"issue":"1","key":"10.1016\/j.dld.2026.03.017_bib0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.advms.2023.12.001","article-title":"Liver fibrosis assessment in pediatric population-can ultrasound elastography be an alternative method to liver biopsy? A systematic review","volume":"69","author":"Medy\u0144ska-Prz\u0119czek","year":"2024","journal-title":"Adv Med Sci"},{"issue":"11","key":"10.1016\/j.dld.2026.03.017_bib0021","article-title":"Accuracy of noninvasive diagnostic tests for the detection of significant and advanced fibrosis stages in nonalcoholic fatty liver disease: a systematic literature review of the US studies","volume":"12","author":"Gosalia","year":"2022","journal-title":"Diagn"},{"key":"10.1016\/j.dld.2026.03.017_bib0022","series-title":"Proceedings of the National Academy of Sciences","article-title":"Chitinase 3-like 1 is a profibrogenic factor overexpressed in the aging liver and in patients with liver cirrhosis","volume":"118","author":"Nishimura","year":"2021"},{"issue":"31","key":"10.1016\/j.dld.2026.03.017_bib0023","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1038\/onc.2017.65","article-title":"Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1","volume":"36","author":"Cohen","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.dld.2026.03.017_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110680","article-title":"CHI3L1 in the pathophysiology and diagnosis of liver diseases","volume":"131","author":"Wang","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"18","key":"10.1016\/j.dld.2026.03.017_bib0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-59745-447-6_7","article-title":"YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation","volume":"511","author":"Roslind","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.dld.2026.03.017_bib0026","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbrc.2022.01.008","article-title":"Chitinase 3-like 1 is involved in the induction of IL-8 expression by double-stranded RNA in airway epithelial cells","volume":"592","author":"Lee","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dld.2026.03.017_bib0027","series-title":"C35. asthma and allergy cellular investigations","article-title":"Emerging role of Ykl-40 In Il-13 induced inflammation in monocyte cells","author":"Nezgovorova","year":"2017"},{"issue":"6","key":"10.1016\/j.dld.2026.03.017_bib0028","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0168-8278(00)80095-1","article-title":"Serum YKL-40 is increased in patients with hepatic fibrosis","volume":"32","author":"Johansen","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2026.03.017_bib0029","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s15010-018-1136-2","article-title":"Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT","volume":"46","author":"Yan","year":"2018","journal-title":"Infection"},{"issue":"6","key":"10.1016\/j.dld.2026.03.017_bib0030","first-page":"793","article-title":"Consensus on the diagnosis and therapy of hepatic fibrosis (2019)","volume":"22","author":"Lu","year":"2019","journal-title":"J Pr Hepatol"},{"issue":"6","key":"10.1016\/j.dld.2026.03.017_bib0031","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.dld.2026.03.017_bib0032","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","article-title":"EASL clinical practice guidelines on the management of hepatitis B virus infection","volume":"83","year":"2025","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2026.03.017_bib0033","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23200","article-title":"The clinical significance of serum chitinase 3-like 1 in hepatitis B-related chronic liver diseases","volume":"34","author":"Jiang","year":"2020","journal-title":"J Clin Lab Anal"},{"issue":"6","key":"10.1016\/j.dld.2026.03.017_bib0034","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/omi.2015.0037","article-title":"CHI3L1 Is a liver-enriched, noninvasive biomarker that can Be used to stage and diagnose substantial hepatic fibrosis","volume":"19","author":"Huang","year":"2015","journal-title":"Omics"},{"issue":"8","key":"10.1016\/j.dld.2026.03.017_bib0035","first-page":"1171","article-title":"Elastography for the non-invasive assessment of liver disease: limitations and future developments","volume":"58","author":"Cross","year":"2009","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.dld.2026.03.017_bib0036","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s15010-018-1136-2","article-title":"Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT","volume":"46","author":"Yan","year":"2018","journal-title":"Infection"},{"issue":"4","key":"10.1016\/j.dld.2026.03.017_bib0037","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.hbpd.2020.05.009","article-title":"Serum chitinase-3-like protein 1 is a biomarker of liver fibrosis in patients with chronic hepatitis B in China","volume":"19","author":"Jin","year":"2020","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.dld.2026.03.017_bib0038","article-title":"Chitinase 3-like protein 1: a diagnostic biomarker for early liver fibrosis in autoimmune liver diseases","volume":"16","author":"Liu","year":"2025","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.dld.2026.03.017_bib0039","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/gut.2008.156489","article-title":"Elastography for the non-invasive assessment of liver disease: limitations and future developments","volume":"58","author":"Vizzutti","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.dld.2026.03.017_bib0040","article-title":"Evaluation of a novel chemiluminescent immunoassay for autoantibody detection in pemphigus and bullous pemphigoid","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.dld.2026.03.017_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.648881","article-title":"Comparison of different test systems for the detection of antiphospholipid antibodies in a Chinese cohort","volume":"12","author":"Hu","year":"2021","journal-title":"Front Immunol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826003300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826003300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:23:24Z","timestamp":1781652204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865826003300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1590865826003300"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2026.03.017","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Explainable machine learning incorporating CHI3L1 enhances liver fibrosis staging in chronic hepatitis B: The CHILI multicenter study","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2026.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}